Alexandra Williams | Director, Strategy and Innovation
AbbVie

Alexandra Williams is a recognized healthcare strategy leader with over 15 years of 340B Drug Pricing Program expertise across provider, consulting, and pharmaceutical sectors. Alexandra serves as Director, Strategy & Innovation, as part of AbbVie’s 340B Center of Excellence, leading the 340B commercial strategy for the organization. Alexandra previously led 340B strategy at Bristol Myers Squibb, OSU Wexner Medical Center, and Apexus (HRSA’s 340B Prime Vendor Program), and served as a 340B auditor on behalf of HRSA. She is a national 340B expert and sought-after conference speaker and educator. Alexandra obtained her Master of Public Health degree from The Ohio State University and her Bachelor of Arts Biology & Health Sciences degree from Guilford College.

Appearances:

Day One @ 15:10

Reforming 340B: What Can Be Done to Regain Program Integrity?

Current status of the 340B rebate pilot (beginning Jan 2027)
How do we improve transparency into the ways hospitals are using 340B revenue?
How can we ensure patients are feeling the benefit?
The role of manufacturers and pharmacies in ensuring program integrity is maintained? (Avoiding duplicate discounts, increasing transparency in claims data submissions)
Are there any supply chain implications?

Moderator: Brian Reid, Principal, Reid Strategic

Alexandra Williams, Director, Strategy and Innovation, AbbVie

Katy Lees, Director, 340B Policy and Business Strategy, University of Rochester Medical Center

Paul Schiferl, 340B Consultant, Citizens Medical Center

Christopher Hatwig, President, Apexus